According to the research report, the global Ewing sarcoma therapeutics market was valued at USD 245.66 million in 2022 and is expected to reach USD 424.42 million by 2032, to grow at a CAGR of 5.7% during the forecast period.
According to the research report, the global Ewing sarcoma therapeutics market was valued at USD 245.66 million in 2022 and is expected to reach USD 424.42 million by 2032, to grow at a CAGR of 5.7% during the forecast period.